Key facts
- Not a listed side effect: Hair loss is not listed as a common adverse reaction in the Ozempic or Wegovy SmPC, but patient reports are widespread
- Main cause: Telogen effluvium — temporary hair shedding triggered by rapid weight loss and caloric deficit
- Onset: Typically 2–4 months after significant weight loss begins
- Duration: Usually resolves within 6–12 months as weight stabilises
- Prevention: Adequate protein (1.0–1.2 g/kg/day), iron, zinc, vitamin D, gradual weight loss
- Tirzepatide data: Hair loss (alopecia) was reported in the SURMOUNT-1 trial at higher rates in the tirzepatide group (5.7%) versus placebo (1.0%)
Is hair loss really linked to Ozempic?
Many patients taking Ozempic (semaglutide) and other GLP-1 receptor agonists report noticeable hair shedding, particularly in the first three to six months of treatment. Social media discussions and patient forums have amplified this concern, leading many to ask whether it is a direct side effect of the medication.
The most likely explanation is not a direct pharmacological effect of semaglutide on hair follicles, but rather a well-recognised physiological response to rapid weight loss called telogen effluvium. This same pattern of hair shedding is observed after bariatric surgery, crash diets, very low-calorie diets, and any medical condition causing significant caloric restriction.
Understanding telogen effluvium
To understand why weight loss causes hair shedding, it helps to know the basics of the hair growth cycle:
- Anagen (growth phase): Lasts 2–7 years. Approximately 85–90% of your hair is in this phase at any given time.
- Catagen (transition phase): Lasts about 2–3 weeks. The follicle shrinks and detaches from the blood supply.
- Telogen (resting phase): Lasts about 3 months. The hair sits in the follicle without growing, then is pushed out by a new anagen hair.
Normally, only about 10 to 15 per cent of your hair is in the telogen phase at once, so daily hair shedding of 50 to 100 hairs is typical. In telogen effluvium, a physiological stress causes a much larger proportion of follicles — sometimes 30 per cent or more — to enter the telogen phase simultaneously. Two to four months later, when these follicles shed their telogen hairs, the result is a noticeable increase in hair fall.
Why rapid weight loss triggers it
Hair growth is metabolically expensive. When the body enters a significant caloric deficit, it prioritises essential functions (brain, heart, organs) and reduces resources allocated to non-essential processes like hair growth. This metabolic reprioritisation pushes a disproportionate number of follicles into telogen. The key triggers include:
- Caloric deficit: Eating significantly fewer calories than the body needs
- Protein insufficiency: Hair is made of keratin, a protein. Insufficient dietary protein directly impairs hair production
- Micronutrient deficiency: Iron, zinc, biotin, vitamin D and B vitamins are all essential for healthy hair growth
- Rapid weight loss rate: Losing more than 1 kg per week increases the risk
- Physiological stress: The hormonal and metabolic changes accompanying significant weight loss act as a physical stressor
Not unique to Ozempic: Telogen effluvium occurs after any form of rapid weight loss. Approximately 30 to 40 per cent of bariatric surgery patients experience noticeable hair shedding in the 3 to 6 months following their procedure. The hair loss associated with GLP-1 medications follows the same pattern and mechanism.
What the clinical data shows
Semaglutide trials (Ozempic and Wegovy)
In the STEP clinical trial programme for Wegovy (semaglutide 2.4 mg weekly for weight management), alopecia (hair loss) was reported as an adverse event but was not among the most common side effects. The SmPC for Ozempic and Wegovy does not list alopecia as a common (1 in 10 to 1 in 100) adverse reaction.
However, pharmacovigilance data and post-marketing reports have accumulated a significant number of hair loss complaints, particularly from patients experiencing rapid weight loss. The temporal pattern — onset 2 to 4 months after starting treatment, coinciding with significant weight loss — is consistent with telogen effluvium rather than a direct drug effect.
Tirzepatide trials (Mounjaro)
In the SURMOUNT-1 trial of tirzepatide (Mounjaro) for weight management, alopecia was reported in 5.7 per cent of patients receiving the highest dose (15 mg) compared with 1.0 per cent receiving placebo. This is one of the clearest signals in a randomised trial, and it correlates with the greater degree of weight loss achieved at higher doses — further supporting the hypothesis that weight loss, rather than the drug itself, is the primary driver.
Nutritional deficiencies to watch for
GLP-1 medications significantly reduce appetite, which can lead to inadequate nutrient intake even in patients who are trying to eat well. The following deficiencies are particularly relevant to hair health:
| Nutrient | Role in hair health | How to get enough |
|---|---|---|
| Protein | Hair is made of keratin (a protein); insufficient intake impairs growth | Aim for 1.0–1.2 g/kg/day: lean meat, fish, eggs, dairy, pulses, tofu |
| Iron | Ferritin (iron stores) below 30–40 µg/L is associated with hair shedding | Red meat, dark leafy greens, fortified cereals; pair with vitamin C for absorption |
| Zinc | Zinc deficiency causes diffuse hair loss and impairs follicle cycling | Shellfish, meat, seeds, nuts, wholegrains |
| Vitamin D | Low vitamin D is associated with telogen effluvium and alopecia areata | Supplement with 10–25 µg/day (UK guidance: at least 10 µg/day in autumn/winter) |
| Biotin (B7) | Biotin deficiency causes hair thinning; however, supplementation does not help if levels are normal | Eggs, nuts, seeds, sweet potato; supplementation only if deficient |
| Vitamin B12 | Deficiency can contribute to hair loss, especially in those with reduced food intake | Meat, fish, dairy, fortified foods; consider supplementation on restricted diets |
How to reduce the risk of hair loss
- Prioritise protein at every meal: Even with reduced appetite, aim for at least 60 g of protein per day. Protein shakes or high-protein snacks can help when large meals feel impossible. See our diet on GLP-1 medication guide for practical tips.
- Avoid excessively rapid weight loss: A steady rate of 0.5 to 1 kg per week is safer for hair retention. If you are losing weight much faster, discuss the dose titration pace with your prescriber.
- Get blood tests: Ask your GP to check ferritin, vitamin D, zinc, B12 and thyroid function before or soon after starting treatment. Correct any deficiencies early.
- Consider a multivitamin: A general multivitamin with iron and zinc can act as nutritional insurance, particularly when caloric intake is significantly reduced.
- Stay hydrated: Dehydration exacerbates hair brittleness and can worsen shedding.
- Be gentle with your hair: Avoid tight hairstyles, excessive heat styling, and harsh chemical treatments during the shedding phase. These do not cause telogen effluvium but can accelerate breakage of already-weakened hair.
- Incorporate resistance training: Maintaining muscle mass supports overall nutritional status and metabolic health during weight loss.
Reassurance: Telogen effluvium is almost always temporary. The shedding looks alarming — seeing extra hair in the shower, on your pillow, or in your brush — but it does not cause permanent baldness. The follicles are not damaged; they are simply cycling through a synchronised resting phase. New growth follows.
When to see your GP
While mild to moderate diffuse hair shedding during weight loss is usually benign and self-limiting, you should see your GP if:
- Hair loss is severe: Losing clumps, visible scalp patches, or significant thinning rather than just increased shedding
- It persists beyond 12 months: Telogen effluvium typically resolves within 6 to 12 months. Persistent hair loss warrants investigation for other causes
- Patchy hair loss: Smooth, well-defined bald patches suggest alopecia areata (an autoimmune condition), not telogen effluvium
- Associated symptoms: Fatigue, brittle nails, skin changes, or cold intolerance may indicate thyroid dysfunction or iron deficiency anaemia
- Hair loss started before weight loss: This may indicate a pre-existing condition unrelated to GLP-1 medication
- You are concerned about your mental wellbeing: Hair loss can have a significant psychological impact. Discuss it with your GP if it is affecting your confidence or mood
Do not stop your medication without medical advice. If you are concerned about hair loss, speak to your prescriber. They may adjust the dose titration, review your nutritional status, or arrange blood tests. Stopping abruptly can lead to rapid weight regain and does not immediately reverse telogen effluvium (the shedding phase takes time to resolve regardless).
Frequently asked questions
Does Ozempic cause hair loss?
Hair loss is not listed as a common side effect in the Ozempic SmPC. However, many patients experience increased hair shedding. This is most likely telogen effluvium, a temporary condition triggered by rapid weight loss and caloric deficit, rather than a direct effect of semaglutide on hair follicles.
What is telogen effluvium?
A temporary hair shedding condition where a large proportion of hair follicles enter the resting phase simultaneously. It is triggered by physiological stress including rapid weight loss, caloric restriction, illness or surgery. Hair shedding typically begins 2 to 4 months after the trigger and resolves within 6 to 9 months.
Will my hair grow back after Ozempic-related hair loss?
In the vast majority of cases, yes. Once weight loss stabilises and nutritional intake is adequate, hair growth returns to normal within 6 to 12 months. Ensuring adequate protein and micronutrient intake supports recovery.
How can I prevent hair loss while taking Ozempic?
Prioritise protein (at least 1.0–1.2 g/kg/day), ensure adequate iron, zinc, biotin and vitamin D, avoid excessively rapid weight loss, stay hydrated, and consider a multivitamin. Ask your GP for baseline blood tests.
When should I see a GP about hair loss on Ozempic?
See your GP if hair loss is severe or patchy, persists beyond 12 months, is accompanied by fatigue or other symptoms, or began before you started losing weight. Do not stop your medication without discussing it with your prescriber first.
Related guides
- GLP-1 Side Effects: What You Need to Know
- Ozempic Side Effects: UK Guide
- Diet on GLP-1 Medication
- Muscle Loss on GLP-1: How to Prevent It
- Exercise on GLP-1 Medication
- Stopping Ozempic: What Happens?
- Ozempic UK: Full Guide
- Wegovy UK: Full Guide
- Mounjaro UK: Cost, NHS Availability and How to Get It
- GLP-1 and Mental Health
Sources
- MHRA — Ozempic and Wegovy Summary of Product Characteristics (SmPC)
- BNF — Semaglutide monograph (bnf.nice.org.uk)
- Jeste M et al. SURMOUNT-1: Tirzepatide in Obesity. N Engl J Med 2022; 387:205-216
- Malkud S. Telogen effluvium: a review. J Clin Diagn Res 2015; 9(9):WE01-WE03
- Guo EL, Katta R. Diet and hair loss: effects of nutrient deficiency and supplement use. Dermatol Pract Concept 2017; 7(1):1-10
- NHS — Hair loss (nhs.uk/conditions/hair-loss)
- British Association of Dermatologists — Telogen Effluvium patient information leaflet
- Mechanick JI et al. Nutritional Guidelines After Bariatric Surgery. Endocr Pract 2013; 19(2):337-372